Resources

PPTA congratulates the province of Alberta for formally adopting the Voluntary Blood Donations Repeal Act, which repeals the existing ban on compensated plasma donation. This landmark legislation allows the citizens of Alberta to join the millions of source plasma donors worldwide who receive a modest compensation for their commitment to providing the starting material for lifesaving therapies to treat the patients who need them. These therapies are relied upon by people facing rare, serious, and life-threatening conditions and are often the only treatment for this vulnerable population.

An online roundtable event entitled “Europe’s need for more plasma – before, during and after Covid-19: challenges and possible solutions”, organized and co-hosted by Member of the European Parliament (MEP) Simona Bonafè, (S&D, Italy) and MEP César Luena (S&D, Spain), and moderated by Peter O’Donnell, a Freelance reporter, took place on December 9, 2020.

Magazine of the plasma protein therapeutics industry - Winter 2020

PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.